Evidence Hub

Phenotypic Clustering of Idiopathic Pulmonary Arterial Hypertension: Insights Into Pulmonary Vascular and Cardiometabolic Co-Morbidity Trajectories

Kaymaz C, Kultursay B, Tokgoz HC, Tanyeri S, Bulus C, Keskin B, Cagliyan CE, Kibar M et al.

Pulmonary circulation, 2026

297 participants

Abstract

Idiopathic pulmonary arterial hypertension (IPAH) exhibits significant clinical heterogeneity, necessitating a precision medicine approach. This study aimed to identify distinct IPAH phenotypes using machine learning-based clustering and to evaluate their longitudinal therapeutic responses and long-term survival. We analyzed 297 IPAH patients using hierarchical agglomerative clustering based on baseline demographics, hemodynamics, and comorbidities. The cohort was characterized by two distinctive yet overlapping phenotypic patterns: Cluster 1 (n = 198, "Pulmonary Vascular Phenotype"), comprising younger patients (median age: 40) with low comorbidity burden but severe hemodynamic impairment, and Cluster 2 (n = 99, "Cardiometabolic Phenotype"), consisting of older, predominantly female patients (median age: 65) with high prevalence of obesity (78%), diabetes (73%), and hypertension (57%). Despite comparable baseline multiparametric risk scores, Cluster 1 exhibited more impaired echocardiographic right ventricular-arterial coupling, lower left ventricular filling pressure and higher pulmonary vascular resistance (p p = 0.048). Linear mixed-effects modeling over 12 months demonstrated that Cluster 1 achieved superior functional recovery (6-min walk distance increase: 75 m vs. 42 m, p p = 0.017). However, during a median follow-up of 763 days, 5-year survival was similar between groups (Log-rank p = 0.452), and cluster membership was not associated with mortality in adjusted Cox…

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 297 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free